Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
| Image |  |
|---|---|
| Description | scientific article published on 30 March 2020 |
| Author/s |
author: Qiaoshuai Lan Linlin Bao Lu Lu Fei Sun |
| Publication date | March 30, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |